Assyro AI

Orange Book product · Brand (NDA)

COMBIVENT RESPIMAT

ALBUTEROL SULFATE; IPRATROPIUM BROMIDE

Brand (NDA)NDA 021747RX BOEHRINGER INGELHEIM

At a glance

Oct 07, 2011

Approved

Brand (NDA)

Application

Not listed

TE code

4

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Oct 07, 2011

    14 yr 11 mo ago

  2. Today

  3. Patent 7396341 expires

    Listed drug product patent expiration.

    Oct 10, 2026

    in 4 mo

  4. Patent 9027967 expires

    Listed drug product patent expiration.

    Mar 31, 2027

    in 10 mo

  5. Patent 7837235 expires

    Listed drug product patent expiration.

    Mar 13, 2028

    in 1 yr 9 mo

  6. Patent 8733341 expires

    Listed drug product patent expiration.

    Oct 16, 2030

    in 4 yr 5 mo

Pharmaceutical detail

Active ingredient

ALBUTEROL SULFATE; IPRATROPIUM BROMIDE

Strength

EQ 0.1MG BASE/INH;0.02MG/INH

Dosage form

SPRAY, METERED

Route

INHALATION

TE code

Not listed

Application

NDA 021747

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (4)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7396341Oct 10, 2026in 4 mo
ProductDelisted
9027967Mar 31, 2027in 10 mo
ProductDelisted
7837235Mar 13, 2028in 1 yr 9 mo
ProductDelisted
8733341Oct 16, 2030in 4 yr 5 mo
ProductDelisted
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.